Skip to main content
Clinical Trials/EUCTR2016-002508-16-DK
EUCTR2016-002508-16-DKActive, not recruitingPhase 1

Optimized photodynamic therapy for basal cell carcinoma

Department of Dermatology D92, Bispebjerg Hospital0 sites50 target enrollmentStarted: July 6, 2016Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • -Primary cell carcinoma (25 superficial and 25 nodular) which have been verified by biopsy
  • -Up to 3 basal cell carcinoma pr. patient
  • -18 years or older
  • -Informed written and oral consent
  • -Fertile women have to use safe contraceptive measures
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

Exclusion Criteria

  • -Basal cell carcinoma localized on the tip of the nose, eyelid, ears, lips, scalp and feet
  • -Basal celle carcinoma > 6 mm thick based on clinical examination
  • -Recurrent tumors
  • -Basal cell carcinom of mophea and infiltrative subtype
  • -Organtransplanted patients
  • -Allergy to the constituents of the used medication
  • -Patients not believed to be able to follow protocol
  • -Pregnancy or breastfeediing

Investigators

Sponsor
Department of Dermatology D92, Bispebjerg Hospital

Similar Trials